Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A specific gene mutation causes congenital hair loss.

AH-001 could be a safer and more effective treatment for hair loss.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Male hormones and reduced plakoglobin can impair heart electrical function and increase arrhythmia risk in males.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

The peach gene CTG134 helps control the interaction between auxin and ethylene, which could lead to new agricultural chemicals.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Tofacitinib may help treat hair loss in children with alopecia areata.

The conditioner with Serenoa serrulata and tocoferol helps reduce hair loss.

Different versions of the KRTAP6-2 gene in goats can lead to thinner cashmere fibers.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

H+-ATPase is crucial for plant growth and can be influenced by microbial compounds, affecting root hair development.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.